Pembrolizumab with chemoradiation for untreated high-risk locally advanced cervical cancer [ID6138]
Awaiting development
Reference number: GID-TA11215
Expected publication date:
NICE has revised the timelines for this evaluation. The committee meeting will now be held on 13 January 2026.
Please note that the project team will reach out to nominated experts directly regarding availability for the new meeting date.